MRK vs SNSE · P/E 33, rev $16.61B vs $18.6M cap
Merck & Company Inc (MRK) versus Sensei Biotherapeutics Inc (SNSE) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Sensei Biotherapeutics Inc (SNSE) is a biotechnology company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
SNSE does not have a complete income-statement cache yet.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. SNSE currently screens at market cap $18.6M.
Not investment advice. Open the MRK and SNSE stock pages for the full models.
Not investment advice.